Australia's most trusted
source of pharma news
Posted 1 December 2021 AM
For the second consecutive year, Bayer's eye drug Eylea has retained its position as the most costly drug to government, while two Hep C medicines dropped off the top 10 list.
According to new government data published in Australian Prescriber today (Wednesday), Eylea used to treat eye conditions such as macular degeneration, cost the taxpayer almost $444 million in the last financial year, topping the list of PBS/RPS drugs ranked by cost to government.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.